1. Impact of age and gender on the safety and efficacy of chemotherapy plus bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies. (1st October 2019) Authors: Marmorino, F; Rossini, D; Lonardi, S; Moretto, R; Zucchelli, G; Aprile, G; Dell'Aquila, E; Ratti, M; Bergamo, F; Masi, G; Urbano, F; Ronzoni, M; Libertini, M; Borelli, B; Randon, G; Buonadonna, A; Allegrini, G; Pella, N; Ricci, V; Boccaccino, A Journal: Annals of oncology Issue: Volume 30:Number 12(2019) Page Start: 1969 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PD-015Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies. (2nd July 2019) Authors: Rossini, D; Sbrana, A; Bergamo, F; Manai, C; Santini, D; Ghidini, M; Antoniotti, C; Moretto, R; Marmorino, F; Urbano, F; Ronzoni, M; Noventa, S; Randon, G; Carlomagno, C; Latiano, T; Cordio, S; Granetto, C; Cremolini, C; Falcone, A; Antonuzzo, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PD-017Clinical and molecular determinants of extrahepatic disease progression (ePD) in initially unresectable, liver-limited metastatic colorectal cancer (mCRC). (20th June 2018) Authors: Ongaro, E; Rossini, D; Pietrantonio, F; Morano, F; de Braud, F; Mazzaferro, V; Corti, F; Randon, G; Raimondi, A; Battaglia, L; Morelli, L; Urbani, L; Masi, G; Moretto, R; Antoniotti, C; Marmorino, F; Borelli, B; Zucchelli, G; Boccaccino, A; Cremolini, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗